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1. Abstract
1.1. Background: Previous research h¬as found that experiences of being diagnosed with Type 2 
Diabetes (T2D) shape how people regard their condition, which can later have an impact on self-
management. This research examines experiences of diagnosis reported by people living with T2D.
1.2. Methods: Using semi-structured interviews (N = 25), focus groups (3 x N = 12 participants) and 
open-ended questionnaires (N = 6), people living with T2D were recruited from a community-based 
T2D participation group. Data were analysed thematically using a framework analysis. 
1.3. Results: Patients’ accounts of diagnosis yielded 3 main themes: (1) Routes to diagnosis; (2) 
Symptom status during diagnosis experience; and (3) Responses to T2D diagnosis. It was found that 
participants’ routes to diagnosis and their experiences of symptoms prior to, and during, the diagnosis 
process presented varying barriers and facilitators to receiving, understanding and/or acting on, the 
ramifications of their condition. This, in turn, shaped how participants’ responded to their diagnosis. 
1.4. Conclusion: The paper concludes that positive experiences of diagnosis may be possible if barriers 
to receiving a T2D diagnosis are removed through health promotion measures. Equally, healthcare 
professionals should seek to resolve the uncertainties that people experience around the time of 
diagnosis. It is recommended that the latter could be achieved by tailoring patient information and 
support according to 1) routes to diagnosis, and 2) the stage of the condition has reached at the time 
of diagnosis.
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3. Background
Type 2 Diabetes (T2D) is a long term condition requiring lifestyle 
changes, such as dietary changes, increased physical activity as 
well as medication-taking. These measures are known collectively 
as self-management which aims to control diabetes and avoid the 
life-threatening complications of the condition. It has long been 
argued that delivery of diagnosis can be a key factor shaping self-
management [1,2]. For example, Polonsky et al [1] investigated the 
levels of distress that patients experienced at the time of diagnosis, 
then measured levels of distress alongside clinical indicators of 
self-management 1-5 years later. It was found that where patients 
reported that healthcare professionals offered reassurance and 
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a clear care plan at the time of diagnosis, that less distress and 
better self-management outcomes were evident in these patients 
1-5 years later. 
A body of, predominantly qualitative, research exists looking at 
people living with diabetes’ experiences of diagnosis. The work of 
Hiscock et al [2] and Peel et al [3] has described how ‘routes’ to 
T2D diagnosis have causal relationships with emotional reactions 
to diagnosis, as well as people’s ability to absorb educational 
information at this time. Hiscock et al [2] suggested that people 
initially experienced a period of reacting to the diagnosis, rather 
than responding to the implications of the diagnosis. As such, 
Hiscock et al [2] recommended that too much information at 
the time of diagnosis was not considered appropriate or helpful 
by patients. However, in Hiscock et al [ibid.] study there was a 
notable bias in recruitment of patients from a diabetes helpline, 
i.e. these people were actively seeking information on T2D self-
management when recruited. Seeking information may have been 
a result of this group experiencing their diagnosis as a shock, rather 
than T2D diagnosis being a shock in all diagnoses. Conversely, 
Peel et al [3] found that this assertion of a global ‘shock’ period 
post-diagnosis was presumptuous. They found three routes to 
diagnosis: the ‘suspected diabetes’ route; ‘illness’ route; and ‘routine’ 
route. The different routes to diagnosis shaped people’s emotional 
responses, and reactions to diagnosis were more complex and 
diverse than just a ‘shock’ scenario. The study [3] also found that 
patients’ requests for information at the time of diagnosis were 
frequently unrelated to ‘emotion’. In the case of a ‘routine testing’ 
diagnosis, the ‘seriousness’ of the illness was often determined by 
the amount and type of information and services that patients were 
offered at this time. Indeed, Parry et al[4]. found that diagnosis is 
a crucial (under-used) point of learning in T2D self-management, 
and that issues of clarity, timing and authority of the diagnosis, i.e. 
how diagnosis was delivered by healthcare professionals, shaped 
patients’ emotional responses. 
Eborall et al [5] argue that qualitative work has shown that people 
diagnosed through screening take T2D less seriously than those 
diagnosed as a result of, for example, hospital admission. Eborall 
et al [ibid]. study showed that perceptions of the illness changed 
over the process of diagnosis, and that it was possible to facilitate 
psychological adjustment through having clear information at 
the time of T2D screening and/or diagnosis, as well as follow up 
information for patients. However, the opt-in nature of research 
and of screening processes (i.e. that characterize Eborall et al 
study sample) may affect the transferability of this research. This is 
because the sample may be comprised largely of participants who 
wanted clarity about, or had an interest in, their current health 
status and would thus respond positively to information-giving. 
Lawton et al [6].found that, following diagnosis, patients felt 
that they lacked the confidence and knowledge to manage T2D, 
and often wanted quick access to services. Troughton et al [7] 
looked at patients with a diagnosis of ‘pre-diabetes’ and found 
that their experiences were characterised by uncertainties about 
their diagnosis, which related to the physical consequences of the 
condition and how to manage them. The study [7] also found that 
patients sought certainty by reading into healthcare professionals’ 
responses in clinical encounters as a gauge of how serious the 
condition was - e.g. how diagnosis was delivered by the health 
professional. Troughton et al [7] also note that the process of 
screening itself demonstrates to (asymptomatic) patients that 
changes that have occurred in their body. However, Weinger et al 
[8] found that patients described a ‘backburner’ phase following 
diagnosis where they felt well, and didn’t prioritize diabetes over 
other issues in their life. However, Lawton et al [6], Troughton 
et al [7] and Weinger et al[8] studies focus on the experiences of 
asymptomatic, newly-diagnosed T2D patients usually diagnosed 
through screening. Hence, these studies tend to preclude the 
experiences of those diagnosed through other routes, e.g. 
hospitalisation or where the patient suspects an illness. 
In overview, looking at responses to diagnosis from the patient’s 
perspective it would appear that although there may be a period of 
shock to diagnosis, and this may not be the norm. Rather, routes 
to, and delivery of, the diagnosis and how information is given at 
the time of diagnosis are influential factors in patients’ perceptions, 
understanding and experiences of diagnosis albeit frequently 
demonstrated solely in newly-diagnosed asymptomatic patients. 
Routes to diagnosis have been shown to influence how patients 
initially respond to diagnosis in the short-term, and that this has an 
association with future self-management outcomes. Less is known 
about how the different mechanisms work in different routes to 
diagnosis. It is also clear that patients experience uncertainty at 
the time of diagnosis which influences the type of information and 
services they would like to receive. This uncertainty can also lead 
to patients looking for external cues in professional attitudes and 
actions to assess the significance of T2D for their lives. However, 
there are gaps in understanding how progression of the illness at 
the time of diagnosis impacts on people’s experiences of diagnosis 
as homogenous samples are largely used, drawn from those recently 
diagnosed by diabetes screening.
Hence, the aim of this study was to explore factors shaping patients’ 
experiences of T2D diagnosis. The objectives in support of this aim 
sought to:
i. Examine the pathways to diagnosis that people living 
with T2D experience;
ii. Explore how progression of the condition at the time of 
diagnosis shaped participants’ experiences;
iii. Describe the barriers and enablers people living with 
T2D perceive and experience during of diagnosis;
iv. Explore how people living with T2D responded to their 
T2D diagnosis (in light of objectives 1, 2 & 3).
4. Methods
Participants were recruited from a Diabetes Patient and Public 
Involvement Group a peer-support group for people living 
with T2D sponsored by a local health provider. A theoretical 
framework and epistemology/ontology informed by critical 
realism was adopted which viewed people’s experiences as 
subjective experiences of their objective circumstances. Using a 
case study approach, members were drawn from one inner London 
borough with diverse socio-demographic population including 
both high levels of deprivation and some of the wealthiest areas 
in the country. A group-based, purposive maximum variation 
sampling approach was taken to capture the naturally occurring 
diversity of people living with T2D, and to ensure participants had 
different routes to, and time since, their diagnosis. Qualitative data 
were collected using three separate methods of data collection to 
maximize: 1) Participation in the study and participant diversity; 
2) Recruitment of irregular attendees of the group and 3) The 
possibility of triangulation between methods. Participants could 
choose to take part in focus groups, and/or one-to-one semi-
structured interviews and/or filling out open-ended questionnaire. 
In total thirty-seven (n=37) participants were recruited (from a 
potential sample of n=166 participation group members). Twenty-
five (n=25) one-to-one interviews were conducted, 6 questionnaires 
and 11 people attended 3 focus groups (n=3,3,5 attendees). Only 
five (n=5) participants participated in more than one method; 
i.e. a questionnaire participant also did a one-to-one interview, 
and 4 focus group participants also went on to do one-to-one 
interviews. Participants were asked questions such as ‘How were 
you diagnosed with Type 2 Diabetes’ and ‘How did you respond 
to your diagnosis’. Data collection continued until saturation point 
was reached. Saturation point occurs where adding participants to 
the existing sample is unlikely to generate any new ideas this is 
estimated to occur anywhere from the 12th [9] to around 25th 
interview [10] or around the third to fifth focus group [11].
All data collected were transcribed verbatim and analysed 
thematically using a data driven, framework analysis approach 
[12]. To ensure rigour, transcripts were also read by two 
researchers (SS, PN) and the thematic framework was developed 
keeping to the agreed themes that emerged, as well as negotiating 
new themes (or sub-themes) where there was disagreement [13]. 
Using framework analysis, quotes from the transcripts were then 
assigned to the themes [14], hence the illustrative quotes given 
in the findings are examples selected from, but representative 
of, all comments in a given theme. Demographic data were 
also collected from participants using a questionnaire to ensure 
participants had diverse characteristics.
Although small from a quantitative, experimental paradigm, 
using qualitative samples of this size have been shown to be robust 
strategy to obtain data which explores patients’ understanding 
and identifies emerging themes using in-depth semi-structured 
designs which often pave the way for further quantitative research 
[14-19]. Ethical clearance was gained from Kings College NHS 
Hospital Research Ethics Committee and signed informed 
consent, anonymity, confidentiality and right to withdraw were 
attained throughout the study. 
5. Findings
The participants who took part in the study were asked to recall 
as clearly as possible their experiences of diagnosis, and to discuss 
the impact that T2D diagnosis on had their day-to-day lives 
at the time. Participants discussed diagnosis as a process where 
T2D was detected, and subsequently diagnosed. The findings 
below are split into four parts. The first section (section 3.1.) 
outlines some of the socio-demographic characteristics of the 
sample. The remaining sections present the main themes found 
in the data: Section 3.2. presents the ‘Routes to diagnosis’ theme; 
Section 3.3. presents the ‘Symptom status during diagnosis’ 
theme; and in Section 3.4., the ‘Responses to T2D diagnosis’ 
theme is presented. As stated above, in the findings presented, 
quotes will be used throughout to illustrate themes. The quotes 
are followed by the abbreviations denoting participant number 
(PT#) and data collection method (interview = I, focus group = 
FG, questionnaire =Qu) e.g. PTI#, PTFG# and PTQn#. A page 
(P.) and line (L.) numbers are also given for all quotes. This allows 
quotes to be traced back to the original transcript e.g. PTI #2, 
P.1:L1. Gender is also given, i.e. (m) or (f ), to allow the reader to 
develop a mental image of the participants.
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5.1.Sample profile
The majority of those taking part were female (57%, N=21) and 
aged 60+ (86%, N=32), the latter being commensurate with the 
onset of T2D amongst older people. Sixty-five per cent (65%; 
n=24) of participants were white with the remaining participants 
self-reporting being black African or black Caribbean. Reflecting 
the deprived nature of the area, only N=6 (16%) participants were 
living in a household with an above average household income. 
Income status tallied with having a higher educational status - 
as the six wealthiest participants were the only ones educated to 
degree level or higher. In contrast, N=7 (22%) of participants lived 
in households with an income which fell below £8,000 per annum 
(p.a.) and these participants were most likely to have education to 
primary school level only. 
5.2. Routes to Diagnosis
The first theme of route to diagnosis had four distinct sub-themes 
reflecting different routes to T2D detection and diagnosis, these 
were:
i. Symptom onset and self-referral diagnoses route;
ii. Screening diagnoses route;
iii. Acute onset/hospitalisation diagnoses route;
iv. Monitoring of a pre-existing condition or a dual diagnoses 
route.
v. These are discussed in turn below. 
5.2.1 Symptom Onset and Self-Referral Diagnoses Route:Of 
the participants who took part in the study, twelve (n=12) received 
a diagnosis as a result of symptom onset and self-referral to health 
services. The symptoms participants detected, prompted self-
referral and eventual diagnosis.“I was not feeling myself, always 
knackered. So I went to the doctor and she did some tests and 
when they came back she said: ‘You’ve got diabetes’” PTI#11 (f ): 
P.2; L.22.
Symptoms followed the classic form of frequent urination, excessive 
thirst and tiredness. Some participants also reported prolonged 
sweats and feet pain as triggers to self-referral. Four ‘self-referring’ 
participants also ‘self-diagnosed’ prior to attending the doctor for a 
formal diagnosis. “I was a psychiatric nurse and I went to work and 
I didn’t feel well. To be honest I used to skip breakfast so I thought 
it was that. I should have noticed the symptoms, I had spoken 
to the doctor before but it was overlooked […] I just realised I 
had diabetes, so I checked [...] All the doctor did was confirm it.” 
PTI#20 (f ) - P.1; L.10.
Two of these patients were able to self-diagnose (through working 
in the health service and/or being able to self-test blood and urine), 
another patient participant’s daughter was a nurse who helped 
to diagnose T2D, and the remaining participant reported that 
he remembered the symptoms from caring for his mother with 
diabetes. As we can see, the participant above had also received an 
early misdiagnosis which acted as a barrier to diagnosis. Conversely, 
her knowledge of T2D, and access to testing equipment, facilitated 
and enabled eventual diagnosis.
5.2.2. Screening Diagnoses Route: A further eleven (n=11) 
participants were informed of their diagnosis as a result of screening 
or ‘M.O.T.s’, as participants frequently referred to the screening 
process. Where symptoms were reported prior to screening these 
were often framed as having known something ‘wasn’t right’ but 
not having known what, or not having recognised the symptoms 
as ‘diabetes’. As such symptoms were retrospectively realised. The 
latter was common where T2D was reported as ‘in the family’ 
suggesting that, in some cases, patients were still able to explain 
away symptoms despite having a familial experience of diabetes.
“I should have spotted it really, my mother had it. But I’d put the 
weight and light-headed feeling down to age. But, of course, it was 
diabetes. I should have seen that.” PTI#13 (m) - P.1; L.18.
Hence, one barrier to diagnosis within the screening route occurred 
where patients reported that they may have had symptoms before 
screening, but that they explained away these symptoms as they 
were so benign. This is why for some participants, the process 
of screening demonstrated to them the effects of T2D when 
symptoms were largely absent.
“I knew that something was wrong with me but I didn’t know what 
it was. When I went to the hospital for some tests, I had to do 
blood and some liquid, and blow into something and when they 
got the results they explained to me I had diabetes and what it is all 
about. The diabetes was happening in my body but I didn’t know.” 
PTI#15(m) - P.1; L.16.
The process of screening itself facilitated these patients’ 
understanding of changes to their bodies which had led to their 
diagnosis, thus facilitating an understanding of their diagnosis. 
But other participants diagnosed through screening reported that 
the delivery of their diagnosis acted as a barrier to understanding 
their diagnosis as diagnosis was delivered inappropriately and with 
insufficient information:
“There wasn’t really any symptoms. I just went to have a check-
up and blood pressure and all that lot. [...] I got back the results, 
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the lady from the surgery called me: ‘You have to come to see the 
doctor you’ve got diabetes.’ I don’t know her, is she a doctor? No. 
This isn’t right, can they do this? It’s my personal information.” 
PTFG#2(f ) - P.6; L.9.
This clearly shows that, in this case, mismanagement of the 
diagnosis delivery by health services had an impact on this 
participant’s experiences at the time of diagnosis.
5.2.3. Acute Onset and Hospitalisation Diagnoses Route: In 
this third sub-theme, participants reported being diagnosed as the 
result of the sudden onset of T2D complications and hospitalisation 
(n=5). Two of these participants reported that diagnosis was given 
when they were admitted to hospital with an ailment that was 
then discovered to be a diabetic complication, e.g. gout.
“I was taken to hospital. It was very sudden, I didn’t know, it was 
just about two weeks, I started drinking a lot but I was in Kenya 
and Kenya was very hot, so I don’t take it very seriously. I just 
thought it was because of the heat and I was running around and 
I was planning to come to visit my children, so I thought I was 
overdoing it, you know. And then finally I started going in and out 
of consciousness and I was taken to the hospital, and I was put in 
intensive care in Nairobi.” PTI#3 (f ) - P.1; L.16.
As we can see, although the participant had some awareness of 
signs of illness and changes to her body these signs were dismissed 
in light of other things happening in her life. Again this route, 
reinforced a key barrier to T2D diagnosis that the symptoms of 
T2D can be readily explained away in the day-to-day context of 
people’s lives, e.g. symptoms are explained away due to hot weather 
or ‘overdoing it’.
5.2.4. Monitoring of a Pre-Existing Condition or a Dual 
Diagnoses Route: The final sub-theme of ‘route to diagnosis’ 
comprised of people who received a dual diagnosis, or were 
diagnosed as a result of monitoring another illness (n=8). Illnesses 
reported included lupus, AIDS, hepatitis B, arthritis and cancer. 
These participants frequently had no experience of T2D symptoms, 
or had only experienced T2D symptoms alongside symptoms of 
other conditions. For example, in discussing the onset of symptoms 
the participant below described how the symptoms of T2D were 
clustered together with HIV status:
“I knew I was ill but it wasn’t what I associated with diabetes and 
I should have recognised it but I just thought it was a type of flu. 
I knew after a week it wasn’t flu but you would have thought the 
health professionals would have spotted it. But I got through it. 
[...] I am a diabetic because of the drugs given me for HIV, it 
turned me into a diabetic, that turned me into a person with high 
blood pressure, that gave me problems with cholesterol and now I 
have got angina.” PTI#10 (m): P.1; L.20 / P.1; L.50. 
Conversely, some participants who reported a comorbidity at the 
time of diagnosis combined their understanding of T2D with the 
co-occurring illness in a way that made the two indistinguishable. 
As this newly-diagnosed patient participant described:
“I was having a lot of problems, which eventually got diagnosed 
mostly as prostate cancer, they included needing to pee fairly 
urgently, feeling rough, therefore eventually I did the un-male 
thing and went to the doctor [...] And first of all blood samples 
a couple of months later I got on to the alternate propositions 
and confirmed as having both. The cancer and the diabetes. [...] 
A bloody nuisance but that so, basically as far as I can work out 
the symptoms are very much the same for both things. So I can’t 
really complain too much about diabetes. I’m not sure if it is that!” 
PTI#2 (m) - P.1; L.8.
Hence, we can see in this route to diagnosis also involved barriers 
to interpreting symptoms where patient participants had to tease 
out the symptoms of T2D from the effects of the co-occurring 
condition.
5.2.5. Overview of Routes to Diagnosis Theme: In overview, 
when describing diagnosis in terms of their ‘route to diagnosis’, 
showed that aspects of their experiences informed barriers to, and 
facilitators of, T2D diagnosis. One patient reported misdiagnosis 
which acted as a healthcare professional-related barrier to a formal 
diagnosis of T2D, but this barrier is possible across all routes to 
diagnosis. Other barriers reported were specific to patients’ routes 
to diagnosis. Patient participants with co-occurring conditions 
reported one barrier to T2D management relating to being unable 
to tease out symptoms specific to T2D. Another barrier, common 
in routes where symptoms were present, was the seemingly benign 
nature of T2D symptoms making it easy to explain some symptoms 
away, which delayed interpretation and self-referral.
Some patients with previous experience of T2D in their family 
saw experience of T2D as facilitating identification of symptoms, 
subsequent self-referral and therefore enabling T2D diagnosis. 
Equally, access to diagnostic equipment facilitated self-diagnosis 
which later led to formal diagnosis. Finally, it was found that some 
patients felt their diagnosis had been un/successfully managed, 
as some participants who received a diagnosis through screening 
described diagnosis as being poorly delivered. Hence it is clear 
that, for some participants, the route to diagnosis had implications 
for the barriers and enablers that participants experienced at the 
time of diagnosis.
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5.3.Symptom Status During Diagnosis
In the second theme of symptom status during diagnosis, patients’ 
awareness and experiences of managing symptoms at the time of 
diagnosis are presented. Six sub-themes of symptom status were 
found based on the participants’ experiences of symptoms and 
the role the patient played in eventually being diagnosed by a 
healthcare professional:
i. Asymptomatic
ii. Awareness of symptoms and self-diagnosis
iii. Awareness of symptoms and self-referral at onset
iv. Uncertain of symptoms and delayed self-referral
v. Apprehensive of symptoms and delayed self-referral
vi. Severe symptoms
Routes to diagnosis engendered different experiences of 
symptoms, purely in terms of how the condition had progressed 
prior to detection or diagnosis. These ranged from asymptomatic, 
to mild, to some patients’ experiencing severe complications. 
Patients were either screened, hospitalised or referred themselves 
to health professionals for diagnosis based on their assessments of 
the symptoms, or for an existing condition. 
5.3.1. Asymptomatic: This sub-theme incorporated patients who 
described themselves as asymptomatic at the time of diagnosis, 
as they were diagnosed with T2D through screening. As such, 
no self-referral to health services occurred and patients had little 
experience of symptoms during diagnosis.
“I went to the clinic for some tests, the annual tests where they test 
blood and so forth and it came out that I was diabetic, which was 
a surprise, as I had no previous symptoms.” PTI#5(m) - P.1; L.15.
These patient participants often reported the process of screening 
itself as demonstrating to them that T2D had ‘occurred in the 
body’, as the quote above stated:“The diabetes was happening in 
my body but I didn’t know.” PTI#15(m) - P.1; L.19.
As noted in the previous section, many of these participants also 
retrospectively said that they felt that something was wrong. 
5.3.2. Awareness of Symptoms and Self-Diagnosis: Patients 
described themselves as aware of their symptoms prior to diagnosis, 
but were not formally diagnosed with T2D, but were briefly self-
diagnosed.
“I had spoken to the doctor before but it was overlooked. [...] I just 
realised I had diabetes, so I checked [...] All the doctor did was 
confirm it.” PTI#20 (f ) - P.1; L.12.
As noted in the previous section, this participant reported having 
had symptoms and suspected they related to T2D. She had 
acknowledged these symptoms by self-referring to a healthcare 
professional. 
5.3.3. Awareness of Symptoms and Self-referral at Onset: Some 
participants described themselves as aware of symptoms prior to 
diagnosis, and were later diagnosed with T2D through self-referral 
to a healthcare professional. These participants described having 
symptoms prior to diagnosis but did not suspect T2D. 
I kept getting really tired, just tired and a bit thirsty. So I went 
to the doctor and they did some tests and there it was‘You’ve got 
diabetes’ PTI#11 (f ): P.1; L.10.
Almost straight away, they acknowledged these symptoms by self-
referral to a healthcare professional, after which they had received 
a diagnosis of T2D.
5.3.4. Uncertain of Symptoms and Delayed Self-Referral: 
Patient participants described themselves as aware of physical 
changes (signs and symptoms) prior to diagnosis, but uncertain 
whether to ascribe these sensations the status of symptoms. These 
symptoms were easy to explain away, therefore, there were delays 
in self-referral and eventual T2D diagnosis.
“...I just thought it was a type of flu...” PTI#10 (m): P.1; L.2.
In this manner, symptoms were also interpreted by patient 
participants as ‘not too serious’ or not prioritised.
“I just thought it was because I was overdoing at work, you know?” 
PTI#5 (f ) - P.1; L.21.
Following a visit to the doctor, a diagnosis was made at a later 
point. It is likely that in severe cases, this accelerated to diagnosis 
by hospitalisation.
5.3.5. Apprehensive of Symptoms and Delayed Self-Referral: 
A few patient participants described themselves as aware of 
physical changes, but feared potentially negative outcomes and 
therefore delayed self-referral and T2D eventual diagnosis. The 
symptoms were viewed as a potentially serious illness, or the 
effect/complications of another pre-existing condition. The actual 
existence and/or effects of the symptoms were then disavowed 
or assigned to a different pre-existing condition or event by the 
patient participant in fear of potentially negative outcomes.
“Sometimes, the way I felt, I probably think I should have gone 
and told the doctor that I’m feeling quite bad […] But usually it 
just goes by itself, comes and goes, and I just couldn’t think tablets 
or injections not really up for that.” PTI#9 (f ) - P.1; L.38.
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The above participant was newly diagnosed with T2D and was 
living with Lupus.
5.3.6. Severe Symptoms: One patient described her symptoms as 
being so severe at the point of diagnosis that she was no longer able 
to respond as the symptoms had affected her judgement. She was 
diagnosed through hospitalisation:
“I had a kind of thing in my brain that somebody wanted to kill 
me, maybe it was the many books I read, you know. And I became 
very uncooperative. And finally, well finally... they managed to put 
me under control and treat me because for the first few days they 
could not come near me, I used to throw cups of tea at nurses and, 
and kicking the lab testing, you know.” PTI#3 (f ) - P.1; L.26.
This participant described a state where her symptoms were so 
advanced she did not have the cognitive ability to identify and 
respond to her symptoms appropriately.
5.3.7. Overview of Symptom Status During Diagnosis: In 
summary, this theme addresses the research question pertaining 
to barriers and facilitators to T2D diabetes. One factor providing 
a barrier to patient self-referral (where symptoms were present) 
was that patient participants were easily able to explain away the 
symptoms of T2D. Patients described how their fear of negative 
outcomes, wider day-to-day commitments and, in some cases, 
co-occurring illness meant symptoms were disavowed or not 
acted on. These factors explained delays in self-referral. Also, in 
extreme cases another barrier to diagnosis may occur when the 
patient becomes unable to respond appropriately due to severe 
complications, particularly in the hospitalisation route. However, 
we can also see that knowledge, prior experience and access to 
testing of T2D facilitated or enabled self-referral in the symptom-
onset and self-referral route. 
5.4.Responses to T2D Diagnosis
Whereas the previous theme focused on how, and whether, 
awareness of symptoms led patients to self-refer for a professional 
diagnosis. This theme looks at the ways participants reported 
responding directly to diagnosis. Only one participant described 
diagnosis as an emotional shock and then denial of diagnosis.
“They kept telling me that I’ve got it, and I kept denying that I’d 
got it, and then I suddenly thought I suppose I’d better go and see 
what they talk about, information and that. So I thought okay I’ll 
go and get some more information and see what it’s like[...] but 
I was just sitting there thinking I haven’t got it.” PTI#9 (f ) - P.4: 
L.45.
Hence, shock and denial responses to T2D diagnosis were rare 
in this sample. Rather, participants’’ responses to diagnosis were 
characterized by either: 
i. Uncertainty about how symptoms were to be identified 
and responded to; or 
ii. Diagnosis as having clarified and addressed the 
uncertainties participants had experienced prior to/during the 
diagnosis process.
5.4.1. Uncertainty about how symptoms were to be identified 
and responded to
The most common response patient participants’ described in 
relation to T2D diagnosis was the experience of uncertainty about 
how to manage the physical manifestations (signs and symptoms) 
of T2D. This continued after formal diagnosis with participants 
describing their responses as being characterized by uncertainty 
about how to manage symptoms now defined as T2D in two ways:
a) What constituted a symptom (symptom uncertainty),
“I just thought it was tiredness, but I felt more tired, exhausted 
really. And I thought it wasn’t right, but didn’t think much of it.” 
PTI#18 (m): P.6; L.7.
 b) The seriousness of symptoms, and therefore whether the 
symptom warranted medical intervention or could be dealt with 
by the individual (response uncertainty) e.g. “Very difficult because 
you can only know so much, you don’t know who to ring. Do I ring 
the GP, the on call doctor, someone at [the Hospital] or just get on 
with it. It could be anything” PTI#25 (f ) - P.1; L.21.
As discussed in sub-section 3.2.4., participants who had a co-
morbidity or dual diagnosis at the time of formal diagnosis also 
experienced a form of symptom uncertainty, as they still found it 
difficult to distinguish between the symptoms of T2D and the co-
occurring illness, and how to manage the co-occurring illnesses in 
conjunction with T2D:
“I have asthma, blood pressure and glaucoma and I have got …and 
something with the liver. Hepatitis, Hepatitis C. That is something 
recently, they just found it recently. And so many pills, and specialist 
for this, diabetes nurse. When I started first I feel funny, because 
there is so many pills to take and I feel so sick that I thought it was 
the tablets. I went to the doctor as well, Dr. [Name], and said just 
wait and see, wait and see, and I need to go back in six months.” 
PTI#6 (f ) - P.1; L.38.
This suggests that it is important that the uncertainties that people 
newly-diagnosed with diabetes experienced are addressed early 
and in a way they can understand and apply as is the case in the 
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next sub-section.
5.4.2. Diagnosis as having clarified and addressed uncertainties
Many participants also reported diagnosis as a ‘relief ’ as it provided 
explanation to the uncertainties they had experienced when 
symptoms had emerged:“I realized I was mortal. It was a real shot 
in the arm. It [diagnosis] explained why I had felt so dreadful” 
PTI#13 (m) - P.3; L.1.
Healthcare professional support at the time of diagnosis was 
also seen by participants as an important way of resolving 
uncertainty:“When I was diagnosed my doctor made an 
appointment for me to go and see him with my husband, and he 
sat down for about twenty minutes and explained everything to us. 
It is very good, and goes into the details of what has caused it, and 
what the symptoms are and what you can do to stop your sugar 
going up. He did spend the time with us, and I think that helped 
my husband as well …” PTFG#3, (f ) - P.10; L.9.
Hence, it was found in contrasting these two sub-themes that the 
degree to which acquiring a diagnosis explained the symptoms of 
T2D and/or how to manage them (i.e. realized by the individual 
or explained by the testing process or healthcare professionals), 
shaped the participants’ response to diagnosis, and vis-à-vis their 
initial confidence in understanding and managing the illness.
4.5.3. Overview of Responses to T2D Diagnosis
Participants’ responses to diagnosis show that only one participant 
reported responding with shock. The majority experienced 
uncertainty about how to respond to the manifestations of T2D 
or how to potentially manage them. Participants’ responses to 
diagnosis also highlight experiences which facilitated a more 
positive understanding of the manifestations of T2D and resolved 
the uncertainties patients experienced. Participants’ described 
experiencing uncertainty about how to respond to the physical 
manifestations of T2D during, and even after, diagnosis. In their 
accounts, participants reported uncertainties relating to identifying 
and responding to symptoms, which acted as a barrier to both 
seeking help and effectively managing symptoms. Hence, given 
that participants had different symptom statuses at the point of 
formal diagnosis, it is important to remember that they will also 
have different levels of experiential knowledge and confidence in 
identifying and responding to symptoms at the time of diagnosis.
What is evident isthat participants’ routes to diagnosis and their 
experiences of symptoms prior to, and during, the diagnosis process 
is that there are barriers and facilitators to receiving, understanding 
and/or acting on, the diagnosis. This in turn shaped participants’ 
responses to their diagnosis as such participants’ experiences can 
be represented as a process with multiple trajectories, as shown in 
(Table 1). 
Route to diagnosis-
T2D was detected/
diagnosed as a result of:
Symptom statuses a, b,c, 
d, e & f
(see key below*)
Responses to T2D
Symptom  
onset and 
self-referral
(n=12)
Symptom 
status: b 
(n=4)
Symptom 
statuses: c, d 
& e (n=8)
1. Potential for response/
symptom uncertainty (pre-
and post-diagnosis) 
2. Potential for diagnosis 
to resolve uncertainty by 
explaining the physical 
manifestations of T2D
Screening
(n=12)
Symptom 
status: a
1. Potential for response/
symptom uncertainty (post-
diagnosis)
2. Potential for diagnosis 
to resolve uncertainty by 
demonstrating or explaining 
the physical manifestations 
of T2D
Onset of 
complications
(and/or) 
hospitalisation 
relating to 
T2D
(n=5)
Symptom 
status: c, d, 
e, & f 
1. Response/symptom uncertainty 
may contribute to late diagnosis
2. Potential for severity to lead to 
inability to respond to physical 
manifestations of T2D
Monitoring of 
a pre-existing 
condition 
(n=5) or a 
dual diagnosis 
(n=3)
Symptom 
status: c, 
d, & e
1. Potential for response/
symptom uncertainty due 
to co-occurrence of another 
condition;
2. Potential for diagnosis 
to resolve uncertainty 
by explaining physical 
manifestations of T2D.
3. T2D symptoms are seen 
as separate to co-occurring 
condition and managed as 
such (pre- or post-diagnosis)
4. T2D symptoms are seen 
as related to, and managed 
as, part of the co-occurring 
condition (pre- or post-
diagnosis)
*Symptom status key: (a) Asymptomatic; (b) Awareness of symptoms and self-
diagnosis; (c) Awareness of symptoms and self-referral at onset; (d) Uncertain 
of symptoms and delayed self-referral; (e) Apprehensive of symptoms and 
delayed self-referral; (f ) Severe symptoms.
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6. Discussion
In contributing to the literature in this area, the present study has 
added an additional route to diagnosis to those found in the work 
of Hiscock et al [2] and Peel et al [3] which were the ‘Symptom 
onset and self-referral diagnoses route’; Screening diagnoses route; 
Acute onset/hospitalization diagnoses route. The present study, by 
taking a heterogeneous sample of people with varying periods of 
time since diagnosis, found a strand of participants who receive a 
diagnosis through dual-diagnosis or through monitoring another 
condition. This group appear to have specific information needs 
relating to managing the ramifications of T2D alongside a co-
occurring condition a situation which is likely to increase given 
the growth of comorbidities in ageing populations [20]. 
Equally, the present study found that routes to diagnosis had 
not only common, but intrinsic, barriers and facilitators which 
shaped participants’ experiences of diagnosis. These barriers and 
facilitators were shaped by: 1) How diagnosis was delivered by 
health services; 2) Experiences of misdiagnosis; and 3) The range 
of factors shaping the individuals’ ability to identify and respond 
to signs and symptoms. Participants accounts highlighted barriers 
to diagnosis that were predominantly T2D-related: i.e. the nature 
of the symptoms can easily be explained away or confused with 
other symptoms which delayed self-referral, or, less frequently, 
T2D symptoms can build so severely its manifestations affect the 
individuals’ capacity to respond. This suggests there is a need to 
enhance diabetes awareness activities within groups vulnerable to 
T2D, particularly around symptom awareness. This was manifest 
in the self-reported patient-related barriers to diagnosis that were 
found, such as the uncertainty and apprehension participants 
reported that led to delayed self-referral, denial of diagnosis and 
confusion about how to self-manage. This suggests some of the 
stigma and fear associated with T2D also needs to be addressed 
through health promotion. Equally, it was found that previous 
knowledge and experience of T2D and access to testing equipment 
amongst patient participants facilitated self-referral for diagnosis 
(acting as an enabler to eventual professional T2D diagnosis). 
To this end, further research into the acceptability, efficiency and 
feasibility of self-testing for T2D is required. At the healthcare 
professional/health service level, misdiagnosis was reported as a 
barrier to diagnosis, and instances of poor management of diagnosis 
were given. On the other hand, (well-managed) diagnosis was seen 
by some participants as demonstrating to them the effects of T2D 
(for example, in screening diagnoses) where the reasons for the 
symptoms they experienced were explained to them. Similar to 
the work of Polonsky et al [1] and Lawton et al [6] it was found 
that where participants were given time and support by healthcare 
professionals and services this facilitated less negative experiences 
of diagnosis. 
The present research also uniquely captured how symptoms were 
managed (by participants) prior to formal diagnosis. It highlights 
that symptoms can be experienced as relatively benign leading 
to varied symptom recognition, or non-recognition, trajectories. 
Some participants successfully symptom-managed prior to formal 
diagnosis through identifying symptoms and responding by self-
referring with some even self-diagnosing. Other participants were 
able to explain away or ignore symptoms, having more important 
priorities. The present study concurs with the work of Peel et 
al [3], Eborall et al [5] on newly diagnosed screening patients 
which suggest that patients are willing and capable of absorbing 
T2D information, and should be given information at the time 
of diagnosis [4]. Supporting the work of Lawton et al [6] and 
Troughton et al [7], the present research also found experiences 
of T2D diagnosis are, for some, characterized by feelings of lack 
of confidence to manage T2D, and by uncertainty. The present 
study, however, added that diagnosis can also resolve uncertainties. 
Building on this, the findings of the present work suggest that 
it is crucial to address and resolve uncertainties for those newly-
diagnosed with T2D as this facilitates understanding in the 
newly-diagnosed of how to adapt to living with the condition. 
In addition, the present study found that different symptom 
statuses at the time of diagnosis and routes to diagnosis confer 
differing practical experiences of managing symptoms prior to 
diagnosis hence different types of experiential knowledge and 
uncertainty amongst the newly diagnosed. This should be reflected 
in healthcare professionals’ informationgiving and support 
approaches to diagnosis.
As with all qualitative data there are limits to the transferability 
of the findings due to the small sample in a specific context. The 
study would benefit from testing whether the components of the 
diagnostic experiences of people living with diabetes described can 
be quantified and measured within the larger diabetic population. 
Equally, as the respondents all came from one group some cross-
contamination of reporting may have occurred. This is a limitation 
of any group-based sampling method, but the sampling method, 
and multiple methods of gathering data, reduced the likelihood of 
this bias through triangulation of data sources. However, the reports 
given were retrospectively meaning there may be problems with 
accurate recall by the participants however, the work of Polonsky 
et al [1] (discussed above) has shown that diagnosis experiences 
can be accurately recalled 1-5 years later. Polonsky et al [1] study 
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found no differences in findings when comparing responses by 
length of time since diagnosis suggesting that deteriorating recall 
of events did not occur, perhaps due to the fact that T2D diagnosis 
is such a significant event in people’s lives. Equally, given the 
common experiences of diagnosis identified from the accounts of 
a diverse range of people with different periods of time since their 
diagnosis it appears this effect of poor recall was minimal in the 
present study.
7. Conclusion
One practical recommendation of this research is that it is crucial 
that there is greater health promotion activity around awareness of 
the signs and symptoms of T2D in groups vulnerable to T2D, and 
the need to seek help if concerned. Equally, given the finding that 
some people self-diagnose, we should seek to remove barriers to 
people self-testing particularly given the potential for confidence-
building this this type of symptom identification and management 
could hold for the newly-diagnosed. At the same time, the fear, 
stigma and apprehension about being diagnosed with T2D should 
be addressed at the population level by emphasising that T2D 
can be self-managed [21] and that support is available, indeed 
normalising self-testing and providing information at this point 
could tackle this fear, stigma and apprehension.
A second practical application of the research relates to the role 
of healthcare professionals and health services. If healthcare 
professionals wish to ensure that newly-diagnosed do not have 
negative experiences of T2D diagnosis, and that their patients 
are equipped to adapt to living with T2D, they need to address 
patients’ uncertainties at the time of diagnosis. At this time, 
information, advice and support need to be tailored to each newly-
diagnosed patient according to their route to diagnosis, experiential 
knowledge of symptoms. Equally, the uncertainties patients have 
experienced prior to, and following diagnosis should be identified 
and addressed. To this end the authors’ wider research has offered 
various continuums and communication tools on how information 
and support can be graduated according to patients’ needs [22, 
23]. Clinical approaches to diagnosis seek to identify, classify 
and ultimately treat a condition. As participants are reading into, 
and learning from, clinical processes of diagnosis, these situations 
should be treated as learning opportunities for both practitioners 
and patients. 
Finally, this research has highlighted that patients’ routes to 
diagnosis are shaped by personal and socio-contextual experiences 
which position the newly-diagnosed on different, and often uneven, 
starting blocks. These experiential pathways have at least an equal, 
if not greater, impact than conferring a clinical diagnosis on how 
people newly-diagnosed with T2D respond to their diagnosis. As 
such common experiences on patients’ pathways to T2D diagnosis 
should be afforded an equal value to clinical approaches to T2D 
diagnosis. 
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